PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat cancers: targeted combo therapy enters Mid-Stage trial
Disease control Not yet recruitingThis study tests a new drug called IBI343 combined with other treatments for people with advanced stomach, gastroesophageal junction, or pancreatic cancers that have a specific marker (CLDN18.2). The goal is to see if the combination is safe and shrinks tumors. About 389 adults w…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Can early genetic testing unlock new cancer treatments?
Knowledge-focused Not yet recruitingThis study tests whether doing broad genetic testing early, instead of later, helps more people with advanced pancreatic, liver, or triple-negative breast cancer get treatments that match their tumor's genetic makeup. About 360 adults with advanced disease will be randomly assign…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 09:55 UTC